Tokyo, July 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058611) titled 'A retrospective observational study on risk factors and postoperative adjuvant therapy for oral cancer' on July 28.
Study Type:
Observational
Primary Sponsor:
Institute - Nagasaki University
Condition:
Condition - Oral cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to examine cases of oral cancer with other risk features and identify cases that are at high risk of recurrence and metastasis and should therefore receive postoperative adjuvant therapy equivalent to that given to high-risk cases, based on recurrence rates and survival rates. Clarifying this will help to determine the appropriate use of postoperative adjuvant therapy and contribute to the future treatment of oral cancer.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Cases treated at the Department of Oral and Maxillofacial Surgery, Nagasaki University Hospital, from April 1, 2001, to April 30, 2024, who underwent primary treatment (primary tumor resection + neck dissection) for oral cancer in accordance with the NCCN guidelines.
Key exclusion criteria - Cases where insufficient information can be obtained due to inadequate medical records
Target Size - 300
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 07 Month 28 Day
Anticipated trial start date - 2025 Year 08 Month 01 Day
Last follow-up date - 2027 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067020
Disclaimer: Curated by HT Syndication.
